Overview

This clinical trial examines the effectiveness in acute low back pain (LBP) of three medications: Ketorolac, Ibuprofen, Diclofenac.

Study Information

This is an interventional study with an estimated 198 participants. It is randomized and double blind for the primary purpose of treating low back pain. The estimated start date of the study is in June 2019 and its estimated completion is in December 2019.

Inclusion Criteria

• All genders, ages 18-64 years old
• Present to ED primary for management of Low Back Pain (LBP)
• Functionally impairing back pain: A baseline score greater than 5 on the Roland-Morris Disability Questionnaire
• Musculoskeletal etiology of low back
• Non-radicular pain.
• Pain duration less than 2 weeks (336 hours)
• Non-traumatic LBP
• Participant is to be discharged home

Exclusion Criteria

• Flank pain: pain originating from tissues lateral to the paraspinal muscles.
• Not available for follow-up
• Pregnant
• Chronic pain syndrome
• Allergic to or intolerant of investigational medications
• Contraindications to investigational medications

Location

You may participate in this study at Montefiore Medical Center in Bronx, New York, United States, 10467. If you have any questions or concerns please contact Eddie Irizarry, MD.

Sponsors/Collaborators

This study is sponsored by Montefiore Medical Center with Eddie Irizarry, MD as the Principal Investigator.